💨 Abstract

Vanda Pharmaceuticals reported a first-quarter loss of $29.5 million (50 cents per share) with $50 million in revenue. The company anticipates full-year revenue between $210 million and $250 million. Separately, the first ballot in the papal conclave did not result in a new pope, as indicated by black smoke from the Sistine Chapel.

Courtesy: wtop.com

Summarized by Einstein Beta 🤖